Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT
Zur Ablage hinzufügen
  Lokale TagsFreigabegeschichteDetailsÜbersicht

Freigegeben
Zeitschriftenartikel

Chronic γ-secretase inhibition reduces amyloid plaque-associated instability of pre- and postsynaptic structures

MPG-Autoren
/persons/resource/persons38965

Liebscher,  Sabine
Department: Synapses-Circuits-Plasticity / Bonhoeffer, MPI of Neurobiology, Max Planck Society;

/persons/resource/persons38769

Bonhoeffer,  Tobias
Department: Synapses-Circuits-Plasticity / Bonhoeffer, MPI of Neurobiology, Max Planck Society;

/persons/resource/persons38901

Hübener,  M.
Department: Synapses-Circuits-Plasticity / Bonhoeffer, MPI of Neurobiology, Max Planck Society;

Externe Ressourcen
Es sind keine externen Ressourcen hinterlegt
Volltexte (beschränkter Zugriff)
Für Ihren IP-Bereich sind aktuell keine Volltexte freigegeben.
Volltexte (frei zugänglich)

mp2013122a.pdf
(beliebiger Volltext), 4MB

Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Liebscher, S., Page, R. M., Käfer, K., Winkler, E., Quinn, K., Goldbach, E., et al. (2014). Chronic γ-secretase inhibition reduces amyloid plaque-associated instability of pre- and postsynaptic structures. Molecular Psychiatry, 19(8), 937-946. doi:10.1038/mp.2013.122.


Zitierlink: https://hdl.handle.net/11858/00-001M-0000-0015-3DA8-E
Zusammenfassung
The loss of synapses is a strong histological correlate of the cognitive decline in Alzheimer’s disease (AD). Amyloid bpeptide (Ab),
a cleavage product of the amyloid precursor protein (APP), exerts detrimental effects on synapses, a process thought to be causally
related to the cognitive deficits in AD. Here, we used in vivo two-photon microscopy to characterize the dynamics of axonal
boutons and dendritic spines in APP/Presenilin 1 (APPswe/PS1L166P)–green fluorescent protein (GFP) transgenic mice. Time-lapse
imaging over 4 weeks revealed a pronounced, concerted instability of pre- and postsynaptic structures within the vicinity of
amyloid plaques. Treatment with a novel sulfonamide-type g-secretase inhibitor (GSI) attenuated the formation and growth of new
plaques and, most importantly, led to a normalization of the enhanced dynamics of synaptic structures close to plaques. GSI
treatment did neither affect spines and boutons distant from plaques in amyloid precursor protein/presenilin 1-GFP (APPPS1-GFP)
nor those in GFP-control mice, suggesting no obvious neuropathological side effects of the drug.